NEW YORK, NY / ACCESS Newswire / April 3, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...

7980. The investigation concerns whether HealthEquity and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of HealthEquity, Inc. (NASDAQ: HQY) resulting from ...

Buying $1000 In HQY: If an investor had bought $1000 of HQY stock 10 years ago, it would be worth $3,618.59 today based on a ...

In the last three months, 4 analysts have published ratings on HealthEquity HQY, offering a diverse range of perspectives from bullish to bearish. The table below provides a concise overview of ...

Mizuho started coverage on HealthEquity in a research report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 target price for the company. Finally, JMP Securities ...

Mizuho started coverage on HealthEquity in a research report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 target price on the stock. JMP Securities raised their ...

HealthEquity logged higher revenue in its fiscal fourth quarter on more user accounts, though its outlook underwhelmed investors. The Draper, Utah., health-savings account custodian on Tuesday ...

Over the past few days HealthEquity (NASDAQ: HQY) shares have been rather sickly. The health savings account (HSA) specialist's stock was rocked by a disappointing earnings report, and as a result ...

Pomerantz LLP is investigating claims on behalf of investors of HealthEquity, Inc (“HealthEquity” or the “Company”) (NASDAQ: HQY). Such investors are advised ...